HRA001106
Title:
Evaluation of NTRK gene fusion by five different platforms in triple-negative breast carcinoma
Release date:
2021-08-04
Description:
Our study was designed to investigate the NTRK gene fusion status in TNBC patients and to determine whether RTK-targeted therapies are suitable for TNBC patients.A total of 305 TNBC patients were enrolled in our study. IHC was employed as a prescreening method, and IHC positive cases were further submitted for evaluation by FISH, RT-PCR, and NGS methods.NTRK IHC was evaluated successfully in 287 of the 305 cases,
Data Accessibility:   
Controlled access Request Data
BioProject:
Study type:
Disease Study
Disease name:
breast carcinoma
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
DAC name:
PUMCH Pathology
Contact person:
Liang Zhiyong
Email:
liangzhiyong1220@yahoo.com
Description:
PUMCH Pathology
Individuals & samples
Submitter:   Liang Zhiyong / liangzhiyong1220@yahoo.com
Organization:   Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
Submission date:   2021-07-30
Requests:   -